Understanding how children's immune systems respond to COVID-19
Early life B cell responses and inflammation following SARS-CoV-2 infection
This study looks at how kids' immune systems respond to COVID-19, especially how well they make antibodies after mild or no symptoms, to understand why they usually get less sick than adults, which could help keep them safe in group settings.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10906934 on NIH RePORTER |
What this research studies
This research investigates the immune responses of children following SARS-CoV-2 infection, focusing on how their bodies produce antibodies against the virus. It aims to understand the strength and duration of these responses, especially in children who experience mild or no symptoms. By analyzing the immune reactions in children, the study seeks to determine why they are less likely to develop severe illness compared to adults. The findings could help inform public health decisions regarding children's safety in congregate settings without vaccination.
Who could benefit from this research
Good fit: Ideal candidates for this research include children aged 0-18 who have been infected with SARS-CoV-2, particularly those with mild or asymptomatic cases.
Not a fit: Patients who are adults or those who have experienced severe COVID-19 symptoms may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding of COVID-19 immunity in children, potentially guiding vaccination strategies and public health policies.
How similar studies have performed: Other research has shown promising results in understanding immune responses to respiratory viruses in children, but this specific focus on SARS-CoV-2 is relatively novel.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Fouda Amou Ou, Genevieve Giny — Weill Medical Coll of Cornell Univ
- Study coordinator: Fouda Amou Ou, Genevieve Giny
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.